McKinley Capital Management’s Pfizer PFE Stock Holding History

McKinley Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-3,236	Closed	-$103K	–	435
2017 Q2	$103K	Buy	+3,236	New	+$102K	﹤0.01%	332
2017 Q1	–	Sell	-1,506,235	Closed	-$46.4M	–	542
2016 Q4	$46.4M	Sell	1,506,235 -64,618	-4%	-$1.97M	1.83%	8
2016 Q3	$50.5M	Buy	1,570,853 +460,663	+41%	+$15.4M	1.82%	8
2016 Q2	$37.1M	Buy	+1,110,190	New	+$35.4M	1.79%	7
2014 Q3	–	Sell	-157,059	Closed	-$4.42M	–	357
2014 Q2	$4.42M	Hold	157,059	–	–	0.18%	132
2014 Q1	$4.79M	Sell	157,059 -18,586	-11%	-$554K	0.2%	120
2013 Q4	$5.1M	Buy	175,645 +4,758	+3%	+$138K	0.2%	115
2013 Q3	$4.66M	Hold	170,887	–	–	0.2%	115
2013 Q2	$4.54M	Buy	+170,887	New	+$4.72M	0.23%	95

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

McKinley Capital Management's PFE Position: Q3 2017 in Review

McKinley Capital Management sold out of Pfizer (PFE) in Q3 2017, closing a stake of 3,236 shares — an estimated $103K sold.

McKinley Capital Management first reported a position in PFE in Q2 2013 and held it in 9 quarters. The position peaked at $50.5M in Q3 2016. 2,042 funds tracked by Wall St. Rank hold PFE as of Q3 2017.

McKinley Capital Management reported no remaining Pfizer position as of Q3 2017 after selling out during the quarter.
McKinley Capital Management sold 3,236 Pfizer shares in Q3 2017, an estimated $103K.
McKinley Capital Management first reported a position in Pfizer in Q2 2013 and held it in 9 quarters.
McKinley Capital Management's Pfizer position peaked at $50.5M in Q3 2016.
2,042 funds tracked by Wall St. Rank held Pfizer as of Q3 2017.

Based on McKinley Capital Management's 13F filing for Q3 2017, filed 13 Nov 2017.